Galapagos NV (Galapagos NV) Other Net Income (Loss) : $235.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Galapagos NV Other Net Income (Loss)?

Galapagos NV's Other Net Income (Loss) for the three months ended in Dec. 2023 was $235.2 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was $235.2 Mil.

Galapagos NV's quarterly Other Net Income (Loss) declined from Jun. 2023 ($0.0 Mil) to Sep. 2023 ($0.0 Mil) but then increased from Sep. 2023 ($0.0 Mil) to Dec. 2023 ($235.2 Mil).

Galapagos NV's annual Other Net Income (Loss) declined from Dec. 2021 ($19.8 Mil) to Dec. 2022 ($-155.3 Mil) but then increased from Dec. 2022 ($-155.3 Mil) to Dec. 2023 ($235.2 Mil).

Galapagos NV Other Net Income (Loss) Historical Data

The historical data trend for Galapagos NV's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Other Net Income (Loss) Chart

Galapagos NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

1.28

6.77

19.84

-155.27

235.21

Galapagos NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-155.27	-	-	-	235.21

Galapagos NV Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $235.2 Mil.

Galapagos NV Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV (Galapagos NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (OTCPK:GLPGF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

GLPG:USA GLPG:Netherlands GLPG:Mexico 0JXZ:UK GXE:Germany GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.